INO - Inovio Pharmaceuticals, Inc.

Day 1m 10m 60m PreMarket Market AfterHours Gap
2.44 0.1 (4.1%) --- --- -0.03 (-1.17%) 0.0 (0.0%) 0.06 (2.41%) 0.0 (0.0%) 0.0 (0.0%)

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.61
Diluted EPS:
-0.61
Basic P/E:
-4.1639
Diluted P/E:
-4.1639
RSI(14) 1m:
0.0
VWAP:
2.54
RVol:
0.7058

Events

Period Kind Movement Occurred At
1m Price decrease 1m 2.55 -0.03 (-1.05%) Oct 15 10:10

Related News